12/10/2015 - 10:40am

For the week of Dec. 6, the top 10 markets with flu activity are predominantly in Texas. 

12/09/2015 - 1:30pm

Keeping the flu bug at bay may mean avoidance of other people or places, including kids. Half (51%) of adults say they limit their contact with children during the flu season. 

12/07/2015 - 3:22pm

Novira, which develops innovative treatments for chronic hepatitis B, will now be part of Janssen Pharmaceuticals’ Infectious Diseases and Vaccines Therapeutic Area. 

12/07/2015 - 1:56pm

Getting 65% of Americans to manage their high levels of LDL cholesterol by 2017 is one of the major targets of the U.S. Department of Health and Human Services’ Million Hearts initiative to prevent one million heart attacks and strokes.

12/04/2015 - 1:40pm

In the letter NACDS sent to all U.S. Senators earlier this week, the association cited the differences in active ingredients in drugs from other countries, as well as different shapes, sizes and colors, which can cause confusion for patients and healthcare professionals.

12/03/2015 - 5:47pm

Attendance at the event, presented by Drug Store News, reached record levels, with 40 retailers and more than 240 supplier participants. 

12/02/2015 - 3:45pm

According to an Associated Press report published in the New York Times, a bipartisan Senate Finance committee report found that Gilead Sciences, maker of hepatitis C treatments Harvoni and Sovaldi, chose to price Sovaldi at $1,000 a pill ($84,000 for a course of treatment) despite evidence that a lower price would allow more people to take advantage of the treatment. Gilead rejected the committee’s conclusions, noting that it “responsibly and thoughtfully priced Sovaldi and Harvoni,” as lawmakers point to this case as a cautionary tale for other expensive treatments. (New York Times)

12/02/2015 - 11:50am

Inquisitr is reporting that a team of medical researchers may have found an off-label use for metformin. According to the research, the drug, which is used to treat people with Type 2 diabetes, can extend a person’s lifespan to 120 years. The researchers are ready to test whether they can replicate in humans the same results they obtained in animal tests, with a 3,000-person study in the works for 2016. (Inquisitr)

12/02/2015 - 10:56am

Rite Aid's Vaccine Central, an assessment tool where visitors can complete a personal immunization evaluation, is an additional resource for people to further review immunization recommendations.